Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
For participants with HIV taking either lopinavir or fosamprenavir who have elevated
triglycerides, this trial will study the change in triglycerides after switching protease
inhibitors.
Phase:
Phase 4
Details
Lead Sponsor:
Community Research Initiative of New England Daniel Skiest, MD